Featured
Gastroenterology: AGA Journal: Published March, 2019Prior research has shown an
association between proton pump inhibitors and fracture risk. This study
checked for markers for bone reabsorption and formation and followed bone
mineral density and the incidence of fractures. It also looked at levels of
calcium, magnesium, phosphorous, and parath...
During
the holy month of Ramadan, Muslims practice daily fasting from dawn to sunset.
This commitment changes their daily food routine in terms of number of meals,
quantity of caloric intake, and types of food consumed. This
change in consumption patterns during Ramadan has an effect on metabolism and
weight, sleeping patterns, and possibly ga...
Neurogastroenterology and Motility Journal: Published:
September 2022GERD is a condition that develops
when the reflux of stomach contents causes troublesome symptoms and/or
complications. These symptoms include typical ones, such as heartburn,
regurgitation, or both, angina-mimicking non-cardiac chest pain, and
extra-esophageal symptoms,...
Gastro-esophageal reflux disease
(GERD) is a disorder involving troublesome symptoms associated with persistent reflux
of gastric contents into the esophagus. Symptoms include heartburn, cough,
epigastric pain, vomiting, and regurgitation.GERD is proposed to have 5 distinct
presentations—nonerosive GERD (NERD), erosive esophagitis (EE), functio...
Dexlansoprazole is a new proton
pump inhibitor (PPI) with a dual delayed-release system. Both dexlansoprazole
and esomeprazole are an enantiomer of lansoprazole and omeprazole respectively.TAKE HOME MESSAGEThis study aims to compare the efficacy of Dexlansoprazole with Esomeprazole
in healing erosive oesophagitis (EO), the maintenance of healed...
International Journal of Molecular Science: Published
on January
2024Gastroesophageal reflux disease
(GERD) is a common disease of the digestive system with a worldwide prevalence
of 8 to 33% and is characterized by the persistent reflux of gastroduodenal
content that ascends through the esophageal tube, causing esophageal and
extraesophageal...
Idiopathic pulmonary fibrosis (IPF) is a chronic,
progressive, fibroinflammatory lung disease associated with increased morbidity
and mortality. As its name suggests, the exact cause of the disease is not
known. However, some genetic and environmental factors have been
observed concurrently with the condition and are considered potential etiolo...
The American Journal of
Gastroenterology
GERD MEDICAL MANAGEMENT
Management
of GERD requires a multifaceted approach, taking into account the symptom
presentation, endoscopic findings, and likely physiological abnormalities.
Medical
management includes lifestyle modifications and pharmacologic therapy,
principally with medication...
Gastroesophageal reflux disease
(GERD) continues to be among the most common diseases seen by
gastroenterologists, surgeons, and primary care physicians. The American College of Gastroenterology (ACG) recently
released an updated guideline on diagnosis and management of GERD which was
published by the American Journal of
Gastroenterology. In t...
Gastroesophageal reflux disease
(GERD) and idiopathic pulmonary fibrosis (IPF) are two pathological conditions
often strictly related, even if a clear relationship of causality has not been
demonstrated.
GERD is a frequent comorbidity in
IPF patients, as demonstrated using combined multichannel intraluminal
impedance-pH, despite being...
Proton Pump Inhibitors (PPIs) are widely considered the
mainstay of medical treatment for GERD. Multiple publications have raised questions about adverse
events, raising doubts about the safety of long-term use and increasing concern
about overprescribing of PPIs. This guideline provides updated, evidence-based recommendations and
practical...
Indian Journal of Gastroenterology: Published:
30 June 2022
TAKE HOME MESSAGE:
Nocturnal acid breakthrough (NAB)
may differ based on duration of proton pump inhibitor (PPI) action and Helicobacter
pylori (H. pylori) infection; NAB may influence esophageal
acidification (EA) and mucosal damage.
Dexlansoprazole, a long-acting PPI,...
